Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx61 Patheon announces date of fiscal 2013 second quarter financial results Full Text Patheon, May 23, 2013
62 Nps pharmaceuticals to present at deutsche bank health care conference Full Text NPS Pharmaceuticals, May 23, 2013
63 NPS pharmaceuticals recognized by national organization for rare disorders for gattex as an innovative treatment for patients with short bowel syndrome Full Text NPS Pharmaceuticals, May 23, 2013
64 NPS pharmaceuticals president and CEO Dr. Francois Nader recognized as regional finalist for ernst & young entrepreneur of the year 2013 Full Text NPS Pharmaceuticals, May 23, 2013
65 Biomarin announces bmn-673 data in breast and ovarian cancers to be released at ASCO Full Text BioMarin, May 23, 2013
66 Biomarin to present at the ubs global healthcare conference Full Text BioMarin, May 23, 2013
67 Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note Full Text Archives of Pharmacal Research, May 23, 2013 Clinical Article
68 CMS: deadline nears to avoid medicare erx payment penalty Full Text Health Data Management, May 22, 2013
69 FDA seeks preliminary injunction against new york fish manufacturer Full Text FDA Press Announcements, May 22, 2013
70 FDA expands alert to health care providers about lack of sterility assurance of all sterile drug products from Nuvision pharmacy Full Text FDA Press Announcements, May 22, 2013
71 Senate confirms tavenner as head of CMS Full Text American Pharmacists Association News, May 22, 2013
72 $15 billion share repurchase program Full Text Merck, May 22, 2013
73 Merck announces $5 billion accelerated share repurchase Full Text Merck, May 22, 2013
74 Abbott announces ce mark for worlds longest coronary drug eluting stent Full Text Abbott, May 22, 2013
75 Vendor scam results in data breach for clinic Full Text Health Data Management, May 22, 2013
76 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 Full Text Boston Scientific, May 22, 2013
77 Change in the board of managing directors at Boehringer Ingelheim Full Text Boehringer Ingelheim, May 22, 2013
78 Administration announces $1b initiative to launch health care innovation awards round two Full Text Healthcare Informatics, May 22, 2013
79 German federal joint committee (g-ba) issues final assessment report for pixuvri (pixantrone) Full Text Cell Therapeutics, May 22, 2013
80 Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement Full Text Novartis, May 22, 2013
1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013 Free full text
2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013 Free full text
3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013 Free full text
4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013 Free full text
5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013 Free full text
6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013 Free full text
7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013 Free full text
8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013 Free full text
9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013 Free full text
10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013 Free full text
11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013 Free full text
12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013 Free full text
13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013 Free full text
14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013 Free full text
15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013 Free full text
16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013 Free full text
17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013 Free full text
18 Astellas pharma us, inc. names new president Astellas, April 3, 2013 Free full text
19 Medivation and astellas provide update on prevail Astellas, April 5, 2013 Free full text
20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close